ES2155450T3 - Anticuerpos opsonicos fuertemente reactivos, que reaccionan a los antigenos comunes de los staphylococcus. - Google Patents

Anticuerpos opsonicos fuertemente reactivos, que reaccionan a los antigenos comunes de los staphylococcus.

Info

Publication number
ES2155450T3
ES2155450T3 ES93907460T ES93907460T ES2155450T3 ES 2155450 T3 ES2155450 T3 ES 2155450T3 ES 93907460 T ES93907460 T ES 93907460T ES 93907460 T ES93907460 T ES 93907460T ES 2155450 T3 ES2155450 T3 ES 2155450T3
Authority
ES
Spain
Prior art keywords
staphylococcus
react
strongly reactive
opsonic antibodies
common antigens
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES93907460T
Other languages
English (en)
Other versions
ES2155450T5 (es
Inventor
Gerald W Fischer
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Henry M Jackson Foundation for Advancedment of Military Medicine Inc
Original Assignee
Henry M Jackson Foundation for Advancedment of Military Medicine Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26709752&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ES2155450(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Henry M Jackson Foundation for Advancedment of Military Medicine Inc filed Critical Henry M Jackson Foundation for Advancedment of Military Medicine Inc
Application granted granted Critical
Publication of ES2155450T3 publication Critical patent/ES2155450T3/es
Publication of ES2155450T5 publication Critical patent/ES2155450T5/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/085—Staphylococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1267—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-positive bacteria
    • C07K16/1271—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-positive bacteria from Micrococcaceae (F), e.g. Staphylococcus
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911—Bacteria
    • G01N33/56938—Staphylococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Hematology (AREA)
  • Microbiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Urology & Nephrology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biophysics (AREA)
  • Cell Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biotechnology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

LA INVENCION SE REFIERE A LA IDENTIFICACION, LA REALIZACION Y EL AISLAMIENTO DE INMUNOGLOBILINA Y ANTIGENO QUE ES UTIL PARA PREVENIR, DIAGNOSTICAR, O TRATAR LA INFECCIONES DE ESTAFILOCOCOS. LA INVENCION SE REFIERE ADEMAS A UN MODELO DE ANIMAL IN VIVO PARA PROBAR LA EFICACIA DE COMPOSICIONES EFICACES, INCLUIDO LAS COMPOSICIONES FARMACEUTICAS DE INMUNOGLOBULINA Y ANTIGENO AISLADO AQUI DESCRITO.
ES93907460T 1992-03-19 1993-03-18 Anticuerpos opsonicos fuertemente reactivos, que reaccionan a los antigenos comunes de los staphylococcus. Expired - Lifetime ES2155450T5 (es)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US85402792A 1992-03-19 1992-03-19
US854027 1992-03-19
US3347693A 1993-03-18 1993-03-18
US33476 1993-03-18

Publications (2)

Publication Number Publication Date
ES2155450T3 true ES2155450T3 (es) 2001-05-16
ES2155450T5 ES2155450T5 (es) 2008-11-01

Family

ID=26709752

Family Applications (1)

Application Number Title Priority Date Filing Date
ES93907460T Expired - Lifetime ES2155450T5 (es) 1992-03-19 1993-03-18 Anticuerpos opsonicos fuertemente reactivos, que reaccionan a los antigenos comunes de los staphylococcus.

Country Status (12)

Country Link
EP (3) EP1027896A1 (es)
JP (3) JP4124816B2 (es)
AT (1) ATE197506T1 (es)
AU (1) AU3805893A (es)
CA (1) CA2132421C (es)
DE (1) DE69329642T3 (es)
DK (1) DK0635132T4 (es)
ES (1) ES2155450T5 (es)
GR (1) GR3035155T3 (es)
IL (1) IL105119A (es)
PT (1) PT635132E (es)
WO (1) WO1993019373A1 (es)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5055455A (en) 1988-09-28 1991-10-08 Brigham And Women's Hospital Capsular polysaccharide adhesin antigen, preparation, purification and use
US5955074A (en) * 1990-10-22 1999-09-21 Henry M. Jackson Foundation For The Advancement Of Military Medicine Directed human immune globulin for the prevention and treatment of staphylococcal infections
US7279162B1 (en) 1990-10-22 2007-10-09 Henry M. Jackson Foundation For The Advancement Of Military Medicine Isolated broadly reactive opsonic immunoglobulin for treating a pathogenic coagulase-negative staphylococcus infection
CA2200691C (en) * 1994-09-21 2011-02-15 Henry M. Jackson Foundation For The Advancement Of Military Medicine Broadly reactive opsonic antibodies reactive with common staphylococcal antigens
AU2006203322B2 (en) * 1997-06-16 2010-04-29 Altor Bioscience Corporation Opsonic and protective monoclonal and chimeric antibodies specific for lipoteichoic acid of gram positive bacteria
US6610293B1 (en) 1997-06-16 2003-08-26 The Henry M. Jackson Foundation For The Advancement Of Military Medicine Opsonic and protective monoclonal and chimeric antibodies specific for lipoteichoic acid of gram positive bacteria
US7250494B2 (en) 1998-06-15 2007-07-31 Biosynexus Incorporated Opsonic monoclonal and chimeric antibodies specific for lipoteichoic acid of Gram positive bacteria
US7252828B2 (en) 1998-07-15 2007-08-07 The Brigham And Women's Hospital, Inc. Polysaccharide vaccine for staphylococcal infections
WO2000071585A1 (en) * 1999-05-03 2000-11-30 Medarex, Inc. Human antibodies to staphylococcus aureus
AU2003290867A1 (en) 2002-11-12 2004-06-03 The Brigham And Women's Hospital, Inc. Methods and products for treating staphylococcal infections
CN100351260C (zh) 2002-11-12 2007-11-28 布赖汉姆妇女医院 葡萄球菌感染的多糖疫苗
EP2439213B1 (en) 2004-04-21 2018-12-12 The Brigham and Women's Hospital, Inc. Poly-N-acetyl glucosamine (PNAG/DPNAG)-binding antibodies and methods of use thereof
CA2583121A1 (en) * 2004-10-21 2007-01-04 Wyeth Immunogenic compositions of staphylococcus epidermidis polypeptide antigens
US20070065919A1 (en) * 2005-08-23 2007-03-22 Herman Groen Methods of producing stable B-lymphocytes
PL1821053T3 (pl) 2006-01-31 2016-04-29 Electrolux Home Products Corp Nv Urządzenie do szybkiego schładzania napojów i sposób jego kontrolowania
BRPI0916365A2 (pt) 2008-07-21 2018-05-02 Brigham & Womens Hospital Inc métodos e composições relacionados aos oligossacarídeos de glicosina beta-1,6 sintéticos
MX2012000044A (es) 2009-06-22 2012-01-30 Wyeth Llc Composiciones inmunogenicas de antigenos de staphylococcus aureus.

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL81370A (en) * 1986-02-07 1991-06-30 Genetic Systems Corp Pharmaceutical and diagnostic compositions comprising a plurality of human monoclonal antibodies for the treatment of bacterial diseases,methods for the preparation of the compositions and antibodies and kits containing said compositions
DE3786173T2 (de) * 1986-12-15 1993-12-16 Mitsui Toatsu Chemicals Menschlicher monoklonaler antikörper und arzneimittel zur prophylaxe und behandlung von infektiösen krankheiten.
CA2117480A1 (en) * 1992-02-25 1993-09-02 Gerald W. Fischer Directed human immune globulin for the prevention and treatment of staphylococcal infections

Also Published As

Publication number Publication date
PT635132E (pt) 2001-03-30
EP0635132A1 (en) 1995-01-25
EP1033135A1 (en) 2000-09-06
JP4124816B2 (ja) 2008-07-23
DE69329642T2 (de) 2001-03-15
IL105119A0 (en) 1993-08-18
ES2155450T5 (es) 2008-11-01
EP0635132B1 (en) 2000-11-08
CA2132421C (en) 2010-11-23
DK0635132T4 (da) 2008-08-25
JP2002255998A (ja) 2002-09-11
GR3035155T3 (en) 2001-04-30
JP2007119468A (ja) 2007-05-17
WO1993019373A1 (en) 1993-09-30
IL105119A (en) 1999-06-20
JP4353974B2 (ja) 2009-10-28
JP4171596B2 (ja) 2008-10-22
DK0635132T3 (da) 2001-02-26
JPH07507387A (ja) 1995-08-10
EP1027896A1 (en) 2000-08-16
CA2132421A1 (en) 1993-09-20
AU3805893A (en) 1993-10-21
ATE197506T1 (de) 2000-11-11
EP0635132B2 (en) 2008-05-14
DE69329642T3 (de) 2009-05-20
DE69329642D1 (de) 2000-12-14

Similar Documents

Publication Publication Date Title
ES2155450T3 (es) Anticuerpos opsonicos fuertemente reactivos, que reaccionan a los antigenos comunes de los staphylococcus.
WO1998057994A3 (en) Opsonic and protective monoclonal and chimeric antibodies specific for lipoteichoic acid of gram positive bacteria
EA199700272A1 (ru) Вакцины, содержащие сапонин и стерин
BR9912702A (pt) Composto e método para a prevenção e/ou para o tratamento de alergias
DE69940545D1 (de) Impfstoffe welche antiidiotypische antikörper enthalten, die kohlenhydrate von streptococcus gruppe b nachahmen
CA2093928A1 (en) Monoclonal antibodies for detection and treatment of cancer
FR2746398B1 (fr) Anticorps specifique de staphylococcus aureaus, et utilisations
EP0584715A3 (de) Gewinnung und Kultivierung transformierter Zellen und Herstellung gegen sie gerichteter Antikörper.
NO870476D0 (no) Fremgangsmaate for fremstilling av kryss-beskyttende humane monoklonale antistoffpreparater.
WO1994010317A3 (en) Conjugate vaccine against group b streptococcus
DK0476226T3 (da) Monoklonalt antistof mod humant IgE
DE69738770D1 (de) Porphyromonas gingivalis Antigene zur Diagnose und Behandlung von Periodontitis
ATE209659T1 (de) Breit-reaktive opsonische antikörper, die mit gemeinsamen staphylococcus-antigenen reagieren
EP0682527A4 (en) CARBON HYDRATE VACCINE AND DIAGNOSTIC REAGENT FOR TRICHINOSIS.
KR900017549A (ko) 암의 혈청진단법
EP0450573A3 (en) Antibodies for the treatment and diagnosis of pseudomonas aeruginosa infections
EP0368466A3 (en) Compositions and methods for the treatment and prevention of gram-negative bacterial infections
PT998493E (pt) Epitopos de toxina semelhante a shigella e a sua utilizacao como vacinas e em diagnosticos
Chekan et al. Natural antibodies against Pseudomonas aeruginosa in human gamma globulin preparations
ATE204761T1 (de) Pharmazeutische antigen-/antikörperpräparation
RU95104325A (ru) Коньюгаты антител с улучшенными свойствами
KR970045107U (ko) 엔진 테스트용 플라이 휠 커플링 플랜지
BRPI9715268B8 (pt) preparações farmacêuticas liofilizadas estáveis de anticorpos monoclonais ou policlonais, bem como processo para sua produção
ZA869335B (en) Monoclonal antibodies cross-reactive and cross-protective against p.aeruginosa serotypes
IT1254955B (it) Anticorpi monoclonali murini diretti contro il polisaccaride capsulare di streptococchi di gruppo b di tipo iii

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 635132

Country of ref document: ES